SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

计划入组 6 人 · 首次发布于 2006 年 8 月 17 日

Vinorelbine for Recurrent ALCL-2017

计划入组 20 人 · 首次发布于 2018 年 2 月 22 日

Vinorelbine for Recurrent ACLC

计划入组 20 人 · 首次发布于 2018 年 1 月 12 日

Anaplastic lymphoma kinase degraders(Cullgen, Inc.)

MALT-1 inhibitors (diffuse large B-cell lymphoma)

BAY-754

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

AIR LIQUIDE LARGE INDUSTRIES U.S. LP

United States

Gamida Cell

Israel

Chugai's Alecensa Receives World's First Tumor-Agnostic Approval for ALK Fusion-Positive Solid Tumors

Pfizer's Crizotinib Explores New Frontier in HER2-Negative Breast Cancer Treatment

Brentuximab Vedotin Shows Strong Real-World Efficacy in Chinese ALCL Patients, Multi-Center Study Finds